نتائج البحث - "Masliak, Zvenyslava"

1

دورية

Phase 3 SELENE study: ibrutinib plus BR/R-CHOP in previously treated patients with follicular or marginal zone lymphoma

المصدر: Blood Advances; November 2023, Vol. 7 Issue: 22 p7141-7150, 10p

2

دورية أكاديمية

Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study

المساهمون: Mohty, Mohamad, Terpos, Evangelo, Mateos, Maria-Victoria, Cavo, Michele, Lejniece, Sandra, Beksac, Meral, Bekadja, Mohamed Amine, Legiec, Wojciech, Dimopoulos, Meletio, Stankovic, Svetlana, Durán, Maria Soledad, De Stefano, Valerio, Corso, Alessandro, Kochkareva, Yulia, Laane, Edward, Berthou, Christian, Salwender, Han, Masliak, Zvenyslava, Pečeliūnas, Valda, Willenbacher, Wolfgang, Silva, João, Louw, Vernon, Nemet, Damir, Borbényi, Zita, Abadi, Uri, Pedersen, Robert Schou, Černelč, Peter, Potamianou, Anna, Couturier, Catherine, Feys, Caroline, Thoret-Bauchet, Florence, Boccadoro, Mario, Lanza, Francesco

مصطلحات موضوعية: Bortezomib, Global, Observational study, Routine practice, Stem cell transplantation

وصف الملف: ELETTRONICO

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/30030033; info:eu-repo/semantics/altIdentifier/wos/WOS:000448262300004; volume:18; issue:10; firstpage:401; lastpage:419; numberofpages:19; journal:CLINICAL LYMPHOMA MYELOMA & LEUKEMIA; https://hdl.handle.net/11585/918890Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85050152150; https://www.sciencedirect.com/science/article/pii/S2152265018302301Test

الإتاحة: https://doi.org/10.1016/j.clml.2018.06.018Test
https://hdl.handle.net/11585/918890Test
https://www.sciencedirect.com/science/article/pii/S2152265018302301Test

View record in BASE

3

دورية أكاديمية

Efficacy and safety of frontline rituximab, cyclophosphamide, doxorubicin and prednisone plus bortezomib (VR-CAP) or vincristine (R-CHOP) in a subset of newly diagnosed mantle cell lymphoma patients medically eligible for transplantation in the randomized, phase 3 LYM-3002 study

المؤلفون: Drach, Johannes, Huang, Huiqiang, Samoilova, Olga, Belch, Andrew, Farber, Charles, Bosly, André, Novak, Jan, Zaucha, Jan, Dascalescu, Angela, Bunworasate, Udomsak, Masliak, Zvenyslava, Vilchevskaya, Kateryna, Robak, Tadeusz, Pei, Lixia, Rooney, Brendan, van de Velde, Helgi, Cavalli, Franco

المصدر: Leukemia & Lymphoma ; volume 59, issue 4, page 896-903 ; ISSN 1042-8194 1029-2403

الإتاحة: https://doi.org/10.1080/10428194.2017.1365855Test

View record in BASE

4

مؤتمر

Multiple myeloma treatment in real-world clinical practice: a focus on induction regimens prior to autologous stem cell transplantation from the prospective, multinational, non-interventional EMMOS study

المصدر: Bone marrow transplantation: vol. 54, suppl. 1: 45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Frankfurt, March 24-27, 2019, London : Nature Publishing Group, 2019, vol. 54, suppl. 1, p. 122-123 ; ISSN 0268-3369 ; eISSN 1476-5365

مصطلحات موضوعية: multiple myeloma, autologous stem cell transplantation, real-world clinical practice

العلاقة: http://vu.lvb.lt/VU:ELABAPDB43679716&prefLang=en_USTest

الإتاحة: http://vu.lvb.lt/VU:ELABAPDB43679716&prefLang=en_USTest

View record in BASE

5

دورية أكاديمية

Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV):a randomised, non-inferiority, phase 3 trial and its extension study

المؤلفون: Gisslinger, Heinz, Klade, Christoph, Georgiev, Pencho, Krochmalczyk, Dorota, Gercheva-Kyuchukova, Liana, Egyed, Miklos, Rossiev, Viktor, Dulicek, Petr, Illes, Arpad, Pylypenko, Halyna, Sivcheva, Lylia, Mayer, Jiri, Yablokova, Vera, Krejcy, Kurt, Grohmann-Izay, Barbara, Hasselbalch, Hans C., Kralovics, Robert, Kiladjian, Jean Jacques, Bauer, Franz, Berbec, Nicoleta, Besses Raebel, Carlos, Borbenyi, Zita, Bumbea, Horia, Buxhofer-Ausch, Veronika, Calbecka, Malgorzata, Cayssials-Caylus, Emilie, Cazzola, Mario, Cerna, Olga, Cucuianu, Andrei, Dima, Delia Monica, Forjan, Ernst, Gheorghita, Emanuil, Greil, Richard, Hatalova, Antonia, Hrubisko, Mikulas, Jakucs, Janos, Kaplan, Polina, Klymenko, Sergiy, Koschmieder, Steffen, Lazaroiu, Mihaela, Lysa, Tamila, Masliak, Zvenyslava, Masszi, Tamas, Mihaylov, Georgi, Myasnikov, Alexander, Platzbecker, Uwe, Puyade, Mathieu, Rey, Jerome, Roy, Lydia, Schwarz, Jiri, Skotnicki, Aleksander, Sokolova, Irina, Soroka-Wojtaszko, Maria, Starzak-Gwozdz, Jolanta, Stoeva, Vera, Torregrosa-Diaz, Jose Miguel, Vallova, Anna, Volodicheva, Elena, Warzocha, Krzysztof, Willenbacher, Ella, Wolf, Dominik

المصدر: Gisslinger , H , Klade , C , Georgiev , P , Krochmalczyk , D , Gercheva-Kyuchukova , L , Egyed , M , Rossiev , V , Dulicek , P , Illes , A , Pylypenko , H , Sivcheva , L , Mayer , J , Yablokova , V , Krejcy , K , Grohmann-Izay , B , Hasselbalch , H C , Kralovics , R , Kiladjian , J J , Bauer , F , Berbec , N , Besses Raebel , C , Borbenyi , Z , Bumbea , H , Buxhofer-Ausch , V , ....

الإتاحة: https://doi.org/10.1016/S2352-3026Test(19)30236-4
https://curis.ku.dk/portal/da/publications/ropeginterferon-alfa2b-versus-standard-therapy-for-polycythaemia-vera-proudpv-and-continuationpvTest(cd59db44-7773-42bd-bc1b-280e1a169f11).html

View record in BASE

6

Аналіз співіснування хронічного мієлопроліферативного та лімфопроліферативного захворювання в одного хворого

المؤلفون: Vygovska, Yaroslava, Boyko, Olha, Masliak, Zvenyslava, Pelenyo, Nataliya, Karol, Yuriy

المصدر: ScienceRise: Medical Science; № 2 (29) (2019); 23-27
ScienceRise. Medical Science; № 2 (29) (2019); 23-27

مصطلحات موضوعية: миелопролиферативное заболевание, лимфопролиферативное заболевание, хроническая лимфоцитарная лейкемия, лимфома, полицитемия, миелофиброз, мієлопроліферативне захворювання, лімфопроліферативне захворювання, хронічна лімфоцитарна лейкемія, лімфома, поліцитемія, мієлофіброз, УДК: 616-006.446.6-06:616.155.392.2]-036.12, myeloproliferative disease, lymphoproliferative disease, chronic lymphocytic leukemia, lymphoma, polycythemia, myelofibrosis

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=scientific_p::a60cbe746d5d67a82622c72c3bac911eTest
http://journals.uran.ua/sr_med/article/view/161767Test

7

مؤتمر

Analysis of Final Data from the Multinational, Non-Interventional, Observational Emmos Study (NCT01241396) in Patients (Pts) with Multiple Myeloma (MM) in Real-World Clinical Practice

المصدر: ASH 57th annual meeting of the American-Society-of-Hematology, Orlando, FL, December 5-8, 2015, ASH, 2015, p. 3034

مصطلحات موضوعية: Emmos Study, Multiple Myeloma, Real-World Clinical Practice

العلاقة: http://vu.lvb.lt/VU:ELABAPDB43678455&prefLang=en_USTest

الإتاحة: http://vu.lvb.lt/VU:ELABAPDB43678455&prefLang=en_USTest

View record in BASE

8

دورية

Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study

المؤلفون: Gisslinger, Heinz, Klade, Christoph, Georgiev, Pencho, Krochmalczyk, Dorota, Gercheva-Kyuchukova, Liana, Egyed, Miklos, Rossiev, Viktor, Dulicek, Petr, Illes, Arpad, Pylypenko, Halyna, Sivcheva, Lylia, Mayer, Jiri, Yablokova, Vera, Krejcy, Kurt, Grohmann-Izay, Barbara, Hasselbalch, Hans C, Kralovics, Robert, Kiladjian, Jean-Jacques, Bauer, Franz, Berbec, Nicoleta, Besses Raebel, Carlos, Borbenyi, Zita, Bumbea, Horia, Buxhofer-Ausch, Veronika, Calbecka, Malgorzata, Cayssials-Caylus, Emilie, Cazzola, Mario, Cerna, Olga, Cucuianu, Andrei, Dima, Delia Monica, Forjan, Ernst, Gheorghita, Emanuil, Greil, Richard, Hatalova, Antonia, Hrubisko, Mikulas, Jakucs, Janos, Kaplan, Polina, Klymenko, Sergiy, Koschmieder, Steffen, Lazaroiu, Mihaela, Lysa, Tamila, Masliak, Zvenyslava, Masszi, Tamas, Mihaylov, Georgi, Myasnikov, Alexander, Platzbecker, Uwe, Puyade, Mathieu, Rey, Jerome, Roy, Lydia, Schwarz, Jiri, Skotnicki, Aleksander, Sokolova, Irina, Soroka-Wojtaszko, Maria, Starzak-Gwozdz, Jolanta, Stoeva, Vera, Torregrosa-Diaz, Jose Miguel, Vallova, Anna, Volodicheva, Elena, Warzocha, Krzysztof, Willenbacher, Ella, Wolf, Dominik

المصدر: The Lancet Haematology; March 2020, Vol. 7 Issue: 3 pe196-e208, 13p

9

مؤتمر

High dose imatinib induction (800 mg/day, 6 months) induces significantly higher cytogenetic and molecular responses in pre-treated chronic phase CML - phase III CELSG 'ISTAHIT' trial - first results

المصدر: Haematologica, Pavia : Ferrata Storti Foundation, 2010, Vol. 95, suppl. 2, p. 53 ; ISSN 0390-6078

العلاقة: http://vu.lvb.lt/VU:ELABAPDB6166663&prefLang=en_USTest

الإتاحة: http://vu.lvb.lt/VU:ELABAPDB6166663&prefLang=en_USTest

View record in BASE

10

مؤتمر

CELSG CML 11 'ISTAHIT' Phase III Study - Planned Interim Analysis : High Doses Of Imatinib Mesylate (800MG/Day) Significantly Improve Rates of Major and Complete Cytogenetic Remissions (MCR, CCR) in Pretreated Ph+/BCR-ABL+ CML Patients in Chronic Phase

المصدر: 50th ASH Annual Meeting and Exposition : San Francisco December 6-9, 2008 : ASCO Annual Meeting Abstracts / American Society of Hematology, San Francisco, 2008, p. no. 6617

مصطلحات موضوعية: Leukemia, myeloid, chronic-phase, Drug therapy, Antineoplastic agents, Administration&dosage, Randomized controlled trials, info:eu-repo/classification/udc/615.277.3

العلاقة: http://lsmu.lvb.lt/LSMU:ELABAPDB5232480&prefLang=en_USTest

الإتاحة: http://lsmu.lvb.lt/LSMU:ELABAPDB5232480&prefLang=en_USTest

View record in BASE

تنقيح النتائج